Vitrolife & Igenomix Middle East, Part Of Vitrolife Group

Vitrolife & Igenomix Middle East, Part Of Vitrolife Group company information, Employees & Contact Information

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.

Company Details

Employees
28
Founded
-
Address
Building 40 Dubai Healthcare City, Unit 501,502 & 512,united Arab Emirates
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Dubai
Looking for a particular Vitrolife & Igenomix Middle East, Part Of Vitrolife Group employee's phone or email?

Vitrolife & Igenomix Middle East, Part Of Vitrolife Group Questions

News

PINNACLE FERTILITY PARTNERS WITH IGENOMIX AS THEIR EXCLUSIVE GENETICS LABORATORY AND GENETIC COUNSELING PROVIDER - PR Newswire

PINNACLE FERTILITY PARTNERS WITH IGENOMIX AS THEIR EXCLUSIVE GENETICS LABORATORY AND GENETIC COUNSELING PROVIDER PR Newswire

A Popular Test Claims to Boost I.V.F. Success. The Science Is Unclear. (Published 2021) - The New York Times

A Popular Test Claims to Boost I.V.F. Success. The Science Is Unclear. (Published 2021) The New York Times

Vitrolife to acquire Igenomix from EQT for $1.48bn - Medical Device Network

Vitrolife to acquire Igenomix from EQT for $1.48bn Medical Device Network

Dentons advises Vitrolife on €1.25 billion acquisition of Igenomix - Iberian Lawyer

Dentons advises Vitrolife on €1.25 billion acquisition of Igenomix Iberian Lawyer

How a breakthrough new fertility test is offering hope for families who have suffered miscarriages - ABC News - Breaking News, Latest News and Videos

How a breakthrough new fertility test is offering hope for families who have suffered miscarriages ABC News - Breaking News, Latest News and Videos

IVF Patients Say a Test Caused Them to Discard Embryos. Now They’re Suing - Time Magazine

IVF Patients Say a Test Caused Them to Discard Embryos. Now They’re Suing Time Magazine

Study Shows Test Used for Some IVF Patients Not Likely Worth Pain, Cost - NBC4 Washington

Study Shows Test Used for Some IVF Patients Not Likely Worth Pain, Cost NBC4 Washington

Dentons advises Vitrolife on €1,25 billion acquisition of Igenomix group of companies - Dentons

Dentons advises Vitrolife on €1,25 billion acquisition of Igenomix group of companies Dentons

Charme III sells control of Spain’s Igenomix to EQT. But it will reinvest for 15%. Deal value is more than 400 mln euros - BeBeez International

Charme III sells control of Spain’s Igenomix to EQT. But it will reinvest for 15%. Deal value is more than 400 mln euros BeBeez International

Igenomix – Reproductive Genetic Testing - Amadeus Capital Partners

Igenomix – Reproductive Genetic Testing Amadeus Capital Partners

A popular test claims to boost IVF success. The science is unclear - Forbes India

A popular test claims to boost IVF success. The science is unclear Forbes India

ART Fertility Clinics appoints David Jimenez to its Board of Directors - ET HealthWorld

ART Fertility Clinics appoints David Jimenez to its Board of Directors ET HealthWorld

(PDF) Mitochondrial DNA content as a viability score in human euploid embryos: Less is better - researchgate.net

(PDF) Mitochondrial DNA content as a viability score in human euploid embryos: Less is better researchgate.net

A Study by Igenomix Opens the Door to Non-invasive Analysis of the Embryo - PR Newswire

A Study by Igenomix Opens the Door to Non-invasive Analysis of the Embryo PR Newswire

Amadeus invests in genetic testing pioneers, Igenomix - Amadeus Capital Partners

Amadeus invests in genetic testing pioneers, Igenomix Amadeus Capital Partners

Igenomix Moves to a Bigger Lab With Updated and Most Efficient Technology - PR Newswire

Igenomix Moves to a Bigger Lab With Updated and Most Efficient Technology PR Newswire

Igenomix Introduces Non-Invasive Prenatal Test, NACE in India - PR Newswire

Igenomix Introduces Non-Invasive Prenatal Test, NACE in India PR Newswire

Top Vitrolife & Igenomix Middle East, Part Of Vitrolife Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant